1 Study Coverage
1.1 Oral Peptide Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Oral Peptide Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Market by Application
1.3.1 Global Oral Peptide Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Peptide Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Peptide Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Peptide Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Peptide Therapy Sales by Region
2.4.1 Global Oral Peptide Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Oral Peptide Therapy by Region (2023-2028)
2.5 Global Oral Peptide Therapy Revenue by Region
2.5.1 Global Oral Peptide Therapy Revenue by Region (2017-2022)
2.5.2 Global Oral Peptide Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Peptide Therapy Sales by Manufacturers
3.1.1 Global Top Oral Peptide Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Peptide Therapy in 2021
3.2 Global Oral Peptide Therapy Revenue by Manufacturers
3.2.1 Global Oral Peptide Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Peptide Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Peptide Therapy Revenue in 2021
3.3 Global Oral Peptide Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Peptide Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Peptide Therapy Sales by Type
4.1.1 Global Oral Peptide Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Oral Peptide Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Peptide Therapy Sales Market Share by Type (2017-2028)
4.2 Global Oral Peptide Therapy Revenue by Type
4.2.1 Global Oral Peptide Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Peptide Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Oral Peptide Therapy Price by Type
4.3.1 Global Oral Peptide Therapy Price by Type (2017-2022)
4.3.2 Global Oral Peptide Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Peptide Therapy Sales by Application
5.1.1 Global Oral Peptide Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Oral Peptide Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Peptide Therapy Sales Market Share by Application (2017-2028)
5.2 Global Oral Peptide Therapy Revenue by Application
5.2.1 Global Oral Peptide Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Peptide Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Oral Peptide Therapy Price by Application
5.3.1 Global Oral Peptide Therapy Price by Application (2017-2022)
5.3.2 Global Oral Peptide Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Peptide Therapy Market Size by Type
6.1.1 North America Oral Peptide Therapy Sales by Type (2017-2028)
6.1.2 North America Oral Peptide Therapy Revenue by Type (2017-2028)
6.2 North America Oral Peptide Therapy Market Size by Application
6.2.1 North America Oral Peptide Therapy Sales by Application (2017-2028)
6.2.2 North America Oral Peptide Therapy Revenue by Application (2017-2028)
6.3 North America Oral Peptide Therapy Market Size by Country
6.3.1 North America Oral Peptide Therapy Sales by Country (2017-2028)
6.3.2 North America Oral Peptide Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral Peptide Therapy Market Size by Type
7.1.1 Europe Oral Peptide Therapy Sales by Type (2017-2028)
7.1.2 Europe Oral Peptide Therapy Revenue by Type (2017-2028)
7.2 Europe Oral Peptide Therapy Market Size by Application
7.2.1 Europe Oral Peptide Therapy Sales by Application (2017-2028)
7.2.2 Europe Oral Peptide Therapy Revenue by Application (2017-2028)
7.3 Europe Oral Peptide Therapy Market Size by Country
7.3.1 Europe Oral Peptide Therapy Sales by Country (2017-2028)
7.3.2 Europe Oral Peptide Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Peptide Therapy Market Size by Type
8.1.1 Asia Pacific Oral Peptide Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Peptide Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Peptide Therapy Market Size by Application
8.2.1 Asia Pacific Oral Peptide Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Peptide Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Peptide Therapy Market Size by Region
8.3.1 Asia Pacific Oral Peptide Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Peptide Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral Peptide Therapy Market Size by Type
9.1.1 Latin America Oral Peptide Therapy Sales by Type (2017-2028)
9.1.2 Latin America Oral Peptide Therapy Revenue by Type (2017-2028)
9.2 Latin America Oral Peptide Therapy Market Size by Application
9.2.1 Latin America Oral Peptide Therapy Sales by Application (2017-2028)
9.2.2 Latin America Oral Peptide Therapy Revenue by Application (2017-2028)
9.3 Latin America Oral Peptide Therapy Market Size by Country
9.3.1 Latin America Oral Peptide Therapy Sales by Country (2017-2028)
9.3.2 Latin America Oral Peptide Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Peptide Therapy Market Size by Type
10.1.1 Middle East and Africa Oral Peptide Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Peptide Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Peptide Therapy Market Size by Application
10.2.1 Middle East and Africa Oral Peptide Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Peptide Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Peptide Therapy Market Size by Country
10.3.1 Middle East and Africa Oral Peptide Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Peptide Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Overview
11.2.3 Novo Nordisk Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novo Nordisk Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novo Nordisk Recent Developments
11.3 Synergy Pharmaceuticals （Salix）
11.3.1 Synergy Pharmaceuticals （Salix） Corporation Information
11.3.2 Synergy Pharmaceuticals （Salix） Overview
11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Chiasma
11.5.1 Chiasma Corporation Information
11.5.2 Chiasma Overview
11.5.3 Chiasma Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chiasma Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chiasma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Peptide Therapy Industry Chain Analysis
12.2 Oral Peptide Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Peptide Therapy Production Mode & Process
12.4 Oral Peptide Therapy Sales and Marketing
12.4.1 Oral Peptide Therapy Sales Channels
12.4.2 Oral Peptide Therapy Distributors
12.5 Oral Peptide Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Peptide Therapy Industry Trends
13.2 Oral Peptide Therapy Market Drivers
13.3 Oral Peptide Therapy Market Challenges
13.4 Oral Peptide Therapy Market Restraints
14 Key Findings in The Global Oral Peptide Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer